Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG.

ABSTRACT:

SUBMITTER: Othus M 

PROVIDER: S-EPMC10662133 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature